Healthy Living: Stopping Cancer’s Spread

Targeted therapies have extended life for HER2 positive breast cancer patients for 20 years, but experts say when the disease reaches stage four it spreads to the brain in over 30 percent of patients.

Those patients were barred from clinical trials for their cancer, until now. 

We break down the HER2 climb study in Healthy Living.

The HER2 climb study opened in 2015 and is still enrolling patients at 171 trial sites.